Value of [18F]Fluorodeoxyglucose Positron Emission Tomography in the Management of Follicular Lymphoma: The End of a Dilemma?
Authors:
- Andrea JanikovaAJAndrea Janikova
- Karol BolcakKBKarol Bolcak
- Tomas PavlikTPTomas Pavlik
- Jiri MayerJMJiri Mayer
- Zdenek KralZKZdenek Kral
- 1 October 2008
- journal article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 8 (5) , 287-293
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The usefulness of 18F‐fluorodeoxyglucose positron emission tomography (18F‐FDG‐PET) and a comparison of 18F‐FDG‐pet with 67gallium scintigraphy in the evaluation of lymphomaCancer, 2007
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in LymphomaJournal of Clinical Oncology, 2007
- Intensity of18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin’s LymphomaJournal of Clinical Oncology, 2005
- Follicular Lymphoma International Prognostic IndexBlood, 2004
- Utility of FDG-PET scanning in lymphoma by WHO classificationBlood, 2003
- Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin’s lymphoma (NHL)Annals of Oncology, 2001
- Follicular lymphoma: Have we made any progress?Annals of Oncology, 2000
- Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s diseaseAnnals of Oncology, 1998
- Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphomaBlood, 1993